|Description||[18F]RPS-041 is a novel labeled PSMA ligand which can be used for detection of prostate cancer by positron emission tomography (PET).|
|Brife Description||PSMA ligand, detection of prostate cancer|
|Application||detection of prostate cancer|
|Current Developer||Weill Cornell Medicine|
FR-168888 Free Base
The free base of FR-168888, a guanidine compound, has been found to be a sodium hydrogen antiporter inhibitor that was once studied in myocardial ischaemia ther...
AM4668 is a potent and selective G-protein coupled receptor 40(GPR40) agonist with EC50 value of 3.6 nM in an IP3 assay in GPR40 transfected A9 cells. It is mor...
BT2 is an allosteric inhibitor of branched-chain α-ketoacid dehydrogenase (BCKDC) kinase (BDK; IC50 = 3.19 μM). BT2 can dissociate BDK from BCKDC via binding to...
Biapenem (INN) is a carbapenem antibiotic. It has in vitro activity against anaerobes.
SX 011 is a potent p38α inhibitor (IC50 = 9 nM). It also acts as a p38β and JNK-2 inhibitor (IC50 = 90 nM and 100 nM, respectively). SX 011 exhibits no signific...
Apoptozole, also known as Apoptosis Activator VII, is an apoptosis-inducing small molecule that inhibits the ATPase activity of heat shock cognate 70 (Hsc70) an...
NPS-1034 is a novel MET inhibitor, which inhibits the activated MET receptor and its constitutively active mutants. NPS-1034, inhibits various constitutively a...
R162 is a potent, selectiv inhibitor of glutamate dehydrogenase 1 (GDH1) (Ki = 28.6 µM), with anti-cancer properties. It does not inhibit the activity of other ...